By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Check-Cap Ltd.

Check-Cap Ltd. (CHEK)

NASDAQ Currency in USD
$0.69
-$0.03
-4.72%
Last Update: 11 Sept 2025, 20:00
$4.01M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.56 - $3.04
52 Week Range

CHEK Stock Price Chart

Explore Check-Cap Ltd. interactive price chart. Choose custom timeframes to analyze CHEK price movements and trends.

CHEK Company Profile

Discover essential business fundamentals and corporate details for Check-Cap Ltd. (CHEK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

4 Mar 2015

Employees

85.00

CEO

Yoav Kimchy

Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

CHEK Financial Timeline

Browse a chronological timeline of Check-Cap Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 4 Jun 2025

Earnings released on 30 Dec 2024

Earnings released on 29 Oct 2024

Earnings released on 13 Sept 2024

EPS came in at -$0.54 falling short of the estimated -$0.17 by -217.30%.

Earnings released on 15 May 2024

EPS came in at -$0.62 surpassing the estimated -$0.87 by +28.74%.

Earnings released on 29 Mar 2024

EPS came in at -$0.64 surpassing the estimated -$0.87 by +26.44%.

Earnings released on 27 Nov 2023

EPS came in at -$0.44 falling short of the estimated -$0.30 by -46.67%.

Earnings released on 4 Aug 2023

EPS came in at -$0.95 falling short of the estimated -$0.45 by -111.11%.

Earnings released on 5 Apr 2023

EPS came in at -$0.71 .

Earnings released on 31 Mar 2023

EPS came in at -$0.64 surpassing the estimated -$0.68 by +5.88%.

Earnings released on 30 Nov 2022

EPS came in at -$0.04 surpassing the estimated -$0.90 by +95.56%.

Stock split effective on 25 Nov 2022

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Aug 2022

EPS came in at -$0.80 surpassing the estimated -$1.00 by +20.00%.

Earnings released on 1 Jun 2022

EPS came in at -$1.20 matching the estimated -$1.20, while revenue for the quarter reached $76.00K .

Earnings released on 7 Apr 2022

EPS came in at -$1.20 falling short of the estimated -$0.50 by -140.00%.

Earnings released on 3 Nov 2021

EPS came in at -$0.80 surpassing the estimated -$1.00 by +20.00%.

Earnings released on 5 Aug 2021

EPS came in at -$1.20 falling short of the estimated -$1.00 by -20.00%.

Earnings released on 12 May 2021

EPS came in at -$1.00 surpassing the estimated -$1.20 by +16.67%.

Earnings released on 19 Mar 2021

EPS came in at -$9.20 falling short of the estimated -$1.40 by -557.14%.

Earnings released on 18 Nov 2020

EPS came in at -$1.80 falling short of the estimated -$1.60 by -12.50%.

CHEK Stock Performance

Access detailed CHEK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run